- Home
- ADT vs ALKS Comparison
ADT vs ALKS Comparison
Compare ADT & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADT
- ALKS
- Stock Information
- Founded
- ADT 1874
- ALKS 1987
- Country
- ADT United States
- ALKS Ireland
- Employees
- ADT N/A
- ALKS N/A
- Industry
- ADT Diversified Commercial Services
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- ADT Consumer Discretionary
- ALKS Health Care
- Exchange
- ADT Nasdaq
- ALKS Nasdaq
- Market Cap
- ADT 6.3B
- ALKS 5.7B
- IPO Year
- ADT 2018
- ALKS 1991
- Fundamental
- Price
- ADT $7.35
- ALKS $35.32
- Analyst Decision
- ADT Hold
- ALKS Buy
- Analyst Count
- ADT 4
- ALKS 12
- Target Price
- ADT $8.55
- ALKS $37.25
- AVG Volume (30 Days)
- ADT 6.2M
- ALKS 1.9M
- Earning Date
- ADT 02-27-2025
- ALKS 02-12-2025
- Dividend Yield
- ADT 3.00%
- ALKS N/A
- EPS Growth
- ADT 2041.84
- ALKS 3.47
- EPS
- ADT 0.98
- ALKS 2.17
- Revenue
- ADT $5,140,300,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- ADT N/A
- ALKS N/A
- Revenue Next Year
- ADT $4.36
- ALKS $4.67
- P/E Ratio
- ADT $7.51
- ALKS $16.28
- Revenue Growth
- ADT 7.14
- ALKS N/A
- 52 Week Low
- ADT $6.10
- ALKS $22.90
- 52 Week High
- ADT $8.25
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- ADT 46.77
- ALKS 71.72
- Support Level
- ADT $7.36
- ALKS $31.01
- Resistance Level
- ADT $7.67
- ALKS $36.45
- Average True Range (ATR)
- ADT 0.18
- ALKS 1.05
- MACD
- ADT -0.03
- ALKS 0.32
- Stochastic Oscillator
- ADT 9.71
- ALKS 81.57
About ADT ADT Inc.
ADT Inc is a provider of monitored security, interactive home and business automation, and related monitoring services in the United States and Canada. It offers residential, commercial, and multi-site customers a comprehensive set of burglary, video, access control, fire and smoke alarm, and medical alert solutions. The company segments include Consumer and Small Business (CSB), Commercial, and Solar. It generates maximum revenue from the Commercial segment.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.